Latest Passive immunity Stories
With the potential to save tens of thousands of lives each year, a new cost-effective rabies therapy developed by MassBiologics at the University of Massachusetts and the Serum Institute of India took an important step forward with positive results from a Phase 1 study.
RESEARCH TRIANGLE PARK, N.C., June 15 /PRNewswire-FirstCall/ -- Talecris Biotherapeutics announced today that it has agreed to a co-promotion arrangement with Novartis Vaccines to jointly market and sell their respective post-exposure rabies products.
KING OF PRUSSIA, Pa., April 19 /PRNewswire/ -- CSL Behring announced today that the U.S.
German scientists say they've created a breed of pea seeds that contain antibodies against coccidiosis, a disease caused by a parasite that attacks chickens. The Novoplant GmbH researchers, led by Sergej Kiprijanov of the German biotechnology company Affitech, developed the genetically modified seeds. There are a few major issues precluding the use of monoclonal antibodies for passive immunization of chickens against infectious diseases, primarily the costs of antibody production and...